4-(4-Hydroxyphenyl)-2-butanone O-[2-galloyl-6-cinnamoylglucoside]



Compound IDCDAMM00550
Common name4-(4-Hydroxyphenyl)-2-butanone O-[2-galloyl-6-cinnamoylglucoside]
IUPAC name[4,5-dihydroxy-2-[4-(3-oxobutyl)phenoxy]-6-(3-phenylprop-2-enoyloxymethyl)oxan-3-yl] 3,4,5-trihydroxybenzoate
Molecular formulaC32H32O12

Experimental data

Retention time13.47
Adduct[M+H]+
Actual mz609.193
Theoretical mz609.196
Error5.54
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score7.6175

Identifiers and class information

Inchi keyAHLBWJHZDLMJOJ-SDNWHVSQNA-N
SmilesO=C(OCC1OC(OC2=CC=C(C=C2)CCC(=O)C)C(OC(=O)C3=CC(O)=C(O)C(O)=C3)C(O)C1O)C=CC=4C=CC=CC4
SuperclassOrganic oxygen compounds
ClassOrganooxygen compounds

Pharmacokinetic properties

Number of descriptor values(#stars)6
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)17
Number of reactive functional groups (#rtvFG)4
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)608.598
Computed dipole moment(dipole)8.05
Total solvent accessible surface area (SASA)926.649
Hydrophobic component of SASA (FOSA)226.954
Hydrophilic component of SASA (FISA)357.687
Pie component of the SASA (PISA)342.008
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)1770.46
Number of hydrogen bond donors (donorHB)5
Number of hydrogen bond acceptors (accptHB)14.1
Free energy of solvation of dipole (dip^2/V)0.0365996
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0340243
Globularity descriptor (glob)0.763789
Predicted polarizability in cubic angstroms (QPpolrz)57.05
Predicted hexadecane/gas partition coefficient (QPlogPC16)20.929
Predicted octanol/gas partition coefficient (QPlogPoct)35.326
Predicted water/gas partition coefficient (QPlogPw)24.17
Predicted octanol/water partition coefficient (QPlogPo/w)1.914
Predicted aqueous solubility (QPlogS)-5.02
Conformation-independent predicted aqueous solubility (CIQPlogS)-6.813
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-6.985
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)4.017
Predicted brain/blood partition coefficient (QPlogBB)-4.549
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)1.272
Predicted skin permeability, log Kp (QPlogKp)-5.275
PM3 calculated ionization potential (IP(ev))9.065
PM3 calculated electron affinity (EA(eV))0.975
Number of likely metabolic reactions (#metab)7
Prediction of binding to human serum albumin (QPlogKhsa)-0.184
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)23.042
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)217.558
Number of nitrogen and oxygen atoms (#NandO)12
Number of violations of Lipinski’s rule of five (RuleOfFive)2
Number of violations of Jorgensen’s rule of three (RuleOfThree)2

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P43166CA7Carbonic anhydrase VIIT37541SEA
P23280CA6Carbonic anhydrase VIT06569SEA
P05121SERPINE1Plasminogen activator inhibitor-1T15556SEA
P35346SSTR5Somatostatin receptor 5T64830SEA
P16109SELPP-selectinT10965SEA
Q9NUW8TDP1Tyrosyl-DNA phosphodiesterase 1T33492SEA
O43826SLC37A4Glucose-6-phosphate translocaseT47306SEA
Q99417MYCBPMYCBP messenger RNAT37298SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T06569DI0046Bacterial infection[ICD-11: 1A00-1C4Z]P23280CA6
T06569DI0372Seborrhoeic dermatitis[ICD-11: EA81]P23280CA6
T15556DI0037Asthma[ICD-11: CA23]P05121SERPINE1
T15556DI0405Thrombosis[ICD-11: DB61-GB90]P05121SERPINE1
T64830DI0108Cushing syndrome[ICD-11: 5A70]P35346SSTR5
T10965DI0088Circulatory system disease[ICD-11: BE2Z]P16109SELP
T10965DI0381Sickle-cell disorder[ICD-11: 3A51]P16109SELP
T37298DI0235Liver cancer[ICD-11: 2C12]Q99417MYCBP

Copyright © 2025